{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T01:01:06Z","timestamp":1785200466550,"version":"3.55.0"},"reference-count":26,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2023,9,12]]},"abstract":"<jats:p>The prevalence of Alzheimer\u2019s disease is greater in women, but the underlying mechanisms remain to be elucidated. We herein demonstrated that \u03b1-secretase ADAM10 was downregulated and ADAM10 inhibitor sFRP1 was upregulated in 5xFAD mice. While there were no sex effects on ADAM10 protein and sFRP1 mRNA levels, female 5xFAD and age-matched non-transgenic mice exhibited higher levels of sFRP1 protein than corresponding male mice. Importantly, female 5xFAD mice accumulated more A\u03b2 than males, and sFRP1 protein levels were positively associated with A\u03b242 levels in 5xFAD mice. Our study suggests that sFRP1 is associated with amyloid pathology in a sex-dependent manner.<\/jats:p>","DOI":"10.3233\/jad-230218","type":"journal-article","created":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T12:41:16Z","timestamp":1691152876000},"page":"399-405","source":"Crossref","is-referenced-by-count":14,"title":["Upregulation of sFRP1 Is More Profound in Female than Male 5xFAD Mice and Positively Associated with Amyloid Pathology"],"prefix":"10.1177","volume":"95","author":[{"given":"Jesse R.","family":"Macyczko","sequence":"first","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suren","family":"Jeevaratnam","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Shue","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Martens","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Chen","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Kanekiyo","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojun","family":"Bu","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghe","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-230218_ref1","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol Med"},{"key":"10.3233\/JAD-230218_ref2","doi-asserted-by":"crossref","first-page":"101496","DOI":"10.1016\/j.arr.2021.101496","article-title":"Past, present and future of therapeutic strategies against amyloid-beta peptides in Alzheimer\u2019s disease: A systematic review","volume":"72","author":"Jeremic","year":"2021","journal-title":"Ageing Res Rev"},{"key":"10.3233\/JAD-230218_ref3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1756-6606-4-3","article-title":"APP processing in Alzheimer\u2019s disease","volume":"4","author":"Zhang","year":"2011","journal-title":"Mol Brain"},{"key":"10.3233\/JAD-230218_ref4","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1073\/pnas.96.7.3922","article-title":"Constitutive and regulated alpha-secretase cleavage of Alzheimer\u2019s amyloid precursor protein by a disintegrin metalloprotease","volume":"96","author":"Lammich","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-230218_ref5","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1038\/emboj.2010.167","article-title":"ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons","volume":"29","author":"Kuhn","year":"2010","journal-title":"EMBO J"},{"key":"10.3233\/JAD-230218_ref6","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1093\/hmg\/ddp323","article-title":"Potential late-onset Alzheimer\u2019s disease-associated mutations in the ADAM10 gene attenuate alpha-secretase activity","volume":"18","author":"Kim","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JAD-230218_ref7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.neuron.2013.08.035","article-title":"ADAM10 missense mutations potentiate beta-amyloid accumulation by impairing prodomain chaperone function","volume":"80","author":"Suh","year":"2013","journal-title":"Neuron"},{"key":"10.3233\/JAD-230218_ref8","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1172\/JCI20864","article-title":"Adisintegrin-metalloproteinase prevents amyloid plaque formation andhippocampal defects in an Alzheimer disease mouse model","volume":"113","author":"Postina","year":"2004","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-230218_ref9","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/j.ymthe.2022.03.024","article-title":"The development of ADAM10 endocytosis inhibitors for the treatment of Alzheimer\u2019s disease","volume":"30","author":"Musardo","year":"2022","journal-title":"Mol Ther"},{"key":"10.3233\/JAD-230218_ref10","doi-asserted-by":"crossref","first-page":"108661","DOI":"10.1016\/j.biopha.2019.108661","article-title":"ADAM10 in Alzheimer\u2019s disease: Pharmacological modulation by natural compounds and its role as a peripheral marker","volume":"113","author":"Manzine","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"10.3233\/JAD-230218_ref11","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/brainsci10020122","article-title":"Enhancing alpha-secretase processing for Alzheimer\u2019s disease-a view on SFRP1","volume":"10","author":"Tang","year":"2020","journal-title":"Brain Sci"},{"key":"10.3233\/JAD-230218_ref12","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1242\/jcs.026096","article-title":"Beyond Wnt inhibition: New functions of secreted Frizzled-related proteins in development and disease","volume":"121","author":"Bovolenta","year":"2008","journal-title":"J Cell Sci"},{"key":"10.3233\/JAD-230218_ref13","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nn.2794","article-title":"SFRPs act as negative modulators of ADAM10 to regulate retinal neurogenesis","volume":"14","author":"Esteve","year":"2011","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-230218_ref14","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/s41593-019-0432-1","article-title":"Elevated levels of Secreted-Frizzled-Related-Protein 1 contribute to Alzheimer\u2019s disease pathogenesis","volume":"22","author":"Esteve","year":"2019","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-230218_ref15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41593-021-00999-y","article-title":"Large-scale deep multi-layer analysis of Alzheimer\u2019s disease brain reveals strong proteomic disease-related changes not observed at the RNA level","volume":"25","author":"Johnson","year":"2022","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-230218_ref16","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.neuron.2019.12.015","article-title":"Deep multilayer brain proteomics identifies molecular networks in Alzheimer\u2019s disease progression","volume":"105","author":"Bai","year":"2020","journal-title":"Neuron"},{"key":"10.3233\/JAD-230218_ref17","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"key":"10.3233\/JAD-230218_ref18","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/archpsyc.62.6.685","article-title":"Sex differences in the clinical manifestations of Alzheimer disease pathology","volume":"62","author":"Barnes","year":"2005","journal-title":"Arch Gen Psychiat"},{"key":"10.3233\/JAD-230218_ref19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41582-018-0032-9","article-title":"Sex differences in Alzheimer disease - the gateway to precision medicine","volume":"14","author":"Ferretti","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-230218_ref20","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: Potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-230218_ref21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1756-6606-3-34","article-title":"Sex- and brain region-specific acceleration of beta-amyloidogenesis following behavioral stress in a mouse model of Alzheimer\u2019s disease","volume":"3","author":"Devi","year":"2010","journal-title":"Mol Brain"},{"key":"10.3233\/JAD-230218_ref22","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.neurobiolaging.2014.02.012","article-title":"Exosome reduction is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer\u2019s disease","volume":"35","author":"Dinkins","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-230218_ref23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12035-022-03065-1","article-title":"Suppression of Wnt\/beta-catenin signaling is associated with downregulation of Wnt1, PORCN, and Rspo2 in Alzheimer\u2019s disease","volume":"60","author":"Macyczko","year":"2023","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-230218_ref24","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1002\/alz.12104","article-title":"Tau and apolipoprotein E modulate cerebrovascular tight junction integrity independent of cerebral amyloid angiopathy in Alzheimer\u2019s disease","volume":"16","author":"Liu","year":"2020","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-230218_ref25","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1016\/j.neurobiolaging.2010.05.027","article-title":"Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Abeta aggregation in the 5XFAD mouse model of Alzheimer\u2019s disease","volume":"33","author":"Jawhar","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-230218_ref26","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1523\/JNEUROSCI.21-02-00372.2001","article-title":"Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer\u2019s disease","volume":"21","author":"Kawarabayashi","year":"2001","journal-title":"J Neurosci"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-230218","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:08:22Z","timestamp":1777370902000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-230218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,12]]},"references-count":26,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jad-230218","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,12]]}}}